Current Report Filing (8-k)
October 22 2020 - 8:47AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (date of earliest event reported): October 22, 2020
Crescent Acquisition Corp
(Exact name of Registrant as specified in its charter)
(310) 235-5900
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following
provisions:
Securities registered pursuant to Section 12(b) of the Act:
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the
Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☒
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial
accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 8.01 Other Events.
Crescent Acquisition Corp (the “Company”) currently intends to hold its first Annual Meeting of Stockholders (the “Annual Meeting”) on December 17, 2020, at a
time and location to be determined and specified in the Company’s definitive proxy statement related to the Annual Meeting. Under the rules of the U.S. Securities and Exchange Commission, the Company has set November 1, 2020 as the deadline for
submitting a shareholder proposal for inclusion in the Company’s proxy materials for the Annual Meeting pursuant to Rule 14a-8 under the Securities Exchange Act of 1934, as amended. Accordingly, in order for a stockholder proposal to be considered
for inclusion in the Company’s proxy materials for the Annual Meeting, the proposal must be received by the Secretary of the Company at the Company’s principal executive offices at 11100 Santa Monica Blvd., Suite 2000, Los Angeles, California 90025,
no later than the close of business on such date, and comply with the procedures and requirements set forth in Rule 14a-8.
In accordance with the advance notice requirements contained in the Bylaws of the Company (the “Bylaws”), for director nominations or other business to be brought
before the Annual Meeting by a stockholder, other than Rule 14a-8 proposals described above, written notice must be delivered to the Secretary of the Company no later than the close of business on November 1, 2020. These stockholder notices also
must comply with the requirements of the Bylaws and will not be effective otherwise.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly
authorized.
Date: October 22, 2020
Crescent Acquisition (NASDAQ:CRSA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Crescent Acquisition (NASDAQ:CRSA)
Historical Stock Chart
From Apr 2023 to Apr 2024